Martrette J M, Hartmann N, Westphal A, Favot L
Département des Sciences Biologiques, Faculté de Chirurgie Dentaire, 96 avenue de Lattre de Tassigny, 54012 Nancy Cedex, France.
J Muscle Res Cell Motil. 2004;25(4-5):297-302. doi: 10.1007/s10974-004-4065-x.
The influence of agonist (dexamethasone) and antagonist (mifepristone) of glucocorticoïd receptor during controllable painless stress was evaluated on myosin heavy chains expression in three masticatory and two nape rat muscles: anterior digastric (AD), anterior temporalis (AT), masseter superficialis (MS), longissimus capitis (L) and rectus capitis dorsalis major (R). The relative amounts of myosin heavy chain (MHC) protein isoform contained were significantly affected in four muscles studied by dexamethasone and in three muscles studied under mifepristone, versus control during the stress procedure, after only 1 week of treatment. The control group AT muscles contained respectively 18.2% of MHC 2A, 34.5% of MHC 2X and 47.4% of MHC 2B. The effects of dexamethasone and mifepristone were opposite in this muscle: under dexamethasone, the relative proportions of the three isoforms were 14.2, 31.0 and 54.8%: consequently, MHC 2A and 2X decreased with the profit of 2B. Under mifepristone, the relative proportions were 21.1, 36.6 and 42.3% (MHC 2A and 2X increased to the detriment of 2B). The L muscle was not affected by the two treatments and MS muscle was only affected by dexamethasone. Dexamethasone increased MHC 2B to the detriment of MHC 2A in MS, AD and R. Mifepristone and dexamethasone induced the same changes in AD. The mifepristone treatment decreased the MHC 2X profile in R. Under dexamethasone, four muscles exhibited a significantly higher proportion of the more rapid isoforms than under mifepristone. A previous work showed that controllable stress induced a marked increase in the relative expression of MHC 2B in the same skeletal muscles (Martrette et al. , 1998). Our results confirm then a significant participation of glucocorticoïd in MHC isoform expression during controllable stress.
在可控无痛应激期间,评估了糖皮质激素受体激动剂(地塞米松)和拮抗剂(米非司酮)对大鼠三块咀嚼肌和两块颈背肌中肌球蛋白重链表达的影响,这几块肌肉分别是:下颌二腹肌前腹(AD)、颞肌前束(AT)、咬肌浅层(MS)、头最长肌(L)和头背直肌大肌(R)。在应激过程中,仅经过1周治疗,与对照组相比,地塞米松对所研究的四块肌肉以及米非司酮对所研究的三块肌肉中所含肌球蛋白重链(MHC)蛋白异构体的相对含量均有显著影响。对照组AT肌肉中,MHC 2A占18.2%,MHC 2X占34.5%,MHC 2B占47.4%。地塞米松和米非司酮对这块肌肉的影响相反:在地塞米松作用下,三种异构体的相对比例分别为14.2%、31.0%和54.8%,因此,MHC 2A和2X减少,MHC 2B增加。在米非司酮作用下,相对比例分别为21.1%、36.6%和42.3%(MHC 2A和2X增加,MHC 2B减少)。L肌肉不受这两种处理的影响,MS肌肉仅受地塞米松影响。在地塞米松作用下,MS、AD和R肌肉中MHC 2B增加,MHC 2A减少。米非司酮和地塞米松对AD肌肉产生相同的变化。米非司酮处理使R肌肉中MHC 2X含量降低。在地塞米松作用下,四块肌肉中比米非司酮作用下更快的异构体比例显著更高。先前的一项研究表明,可控应激会使相同骨骼肌中MHC 2B的相对表达显著增加(Martrette等人,1998年)。因此,我们的结果证实了糖皮质激素在可控应激期间对MHC异构体表达有重要作用。